Urinary leukotriene E4 excretion is increased in type 1 diabetic patients: A quantification by liquid chromatography–tandem mass spectrometry
- 31 December 2005
- journal article
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 78 (1-4), 291-299
- https://doi.org/10.1016/j.prostaglandins.2005.10.001
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Lipid Inflammatory Mediators in Diabetic Vascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic EventsCirculation, 2004
- Enhanced Lipid Peroxidation and Platelet Activation in the Early Phase of Type 1 Diabetes MellitusCirculation, 2003
- Inflammation in Cardiovascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Mortality and causes of death in the WHO multinational study of vascular disease in diabetesDiabetologia, 2001
- Measurement of Leukotrienes in HumansAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Urinary thromboxane A2/prostacyclin balance reflects the pathological state of a diabeticProstaglandins & Other Lipid Mediators, 1999
- In Vivo Formation of 8-Iso-Prostaglandin F 2α and Platelet Activation in Diabetes MellitusCirculation, 1999
- A 12-lipoxygenase product, 12-hydroxyeicosatetraenoic acid, is increased in diabetics with incipient and early renal diseaseJournal of Clinical Endocrinology & Metabolism, 1996
- URINARY LEUKOTRIENE E4 AFTER ANTIGEN CHALLENGE AND IN ACUTE ASTHMA AND ALLERGIC RHINITISThe Lancet, 1989